tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

YS

YS Biopharma Rebrands to LakeShore Biopharma
Company AnnouncementsYS Biopharma Rebrands to LakeShore Biopharma
2M ago
6K
YS
YS Biopharma announces name change to ‘LakeShore Biopharma’
PremiumThe Fly
YS Biopharma announces name change to ‘LakeShore Biopharma’
2M ago
YS
YS Biopharma Approves Major Corporate Changes
PremiumCompany Announcements
YS Biopharma Approves Major Corporate Changes
2M ago
6K
YS
YS Biopharma granted additional 180 day extension by Nasdaq to regain compliance
PremiumThe Fly
YS Biopharma granted additional 180 day extension by Nasdaq to regain compliance
3M ago
YS
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
PremiumPress Releases
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
3M ago
YS
YS Biopharma: YS-HBV-002 vaccine granted clinical trial approval by PFDA
PremiumThe FlyYS Biopharma: YS-HBV-002 vaccine granted clinical trial approval by PFDA
3M ago
YS
YS Biopharma’s PIKA Rabies Vaccine meets Phase 3 primary endpoints
PremiumThe Fly
YS Biopharma’s PIKA Rabies Vaccine meets Phase 3 primary endpoints
4M ago
YS
YS Biopharma to sell 95.269M shares at 41.99c in private placement
PremiumThe Fly
YS Biopharma to sell 95.269M shares at 41.99c in private placement
6M ago
YS
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
PremiumPress Releases
YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
6M ago
YS
YS Biopharma responds to press release on extraordinary general meeting
PremiumThe Fly
YS Biopharma responds to press release on extraordinary general meeting
7M ago
YS
YS Biopharma initiated with an Outperform at Noble Capital
PremiumThe Fly
YS Biopharma initiated with an Outperform at Noble Capital
9M ago
YS
YS Biopharma completion enrollment in Phase 3 clinical trial of rabies vaccine
PremiumThe Fly
YS Biopharma completion enrollment in Phase 3 clinical trial of rabies vaccine
9M ago
YS
YS Biopharma receives Nasdaq noncompliance notice
PremiumThe FlyYS Biopharma receives Nasdaq noncompliance notice
9M ago
YS
YS Biopharma enrolls first subject in Phase 3 clinical trial of rabies vaccine
PremiumThe Fly
YS Biopharma enrolls first subject in Phase 3 clinical trial of rabies vaccine
10M ago
YS
YS Biopharma granted new patent covering PIKA YS-HBV-002
PremiumThe Fly
YS Biopharma granted new patent covering PIKA YS-HBV-002
11M ago
YS
YS Biopharma officers purchase shares
PremiumThe Fly
YS Biopharma officers purchase shares
11M ago
YS
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
PremiumPress Releases
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
12M ago
YS
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023
PremiumPress Releases
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023
1y ago
YS
YS Biopharma Gains after Releasing Preliminary Results
PremiumMarket News
YS Biopharma Gains after Releasing Preliminary Results
1y ago
YS
YS Biopharma sees FY23 revenue up 30% to $103M
PremiumThe FlyYS Biopharma sees FY23 revenue up 30% to $103M
1y ago
YS
YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023
PremiumPress Releases
YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023
1y ago
YS
YS Biopharma announces COVID-19 Vaccine study met primary, secondary endpoints
PremiumThe Fly
YS Biopharma announces COVID-19 Vaccine study met primary, secondary endpoints
1y ago
YS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >